Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$25.16 -0.13 (-0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcutis Biotherapeutics (ARQT) Cash & Current Investments (2019 - 2026)

Updated

Arcutis Biotherapeutics (ARQT) recorded Cash & Current Investments of $204.43 million in Q2 2026, up 73.1% from $118.08 million a year earlier and up 8.0% from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Arcutis Biotherapeutics reported Cash & Current Investments of $178.08 million, up 13.7% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of -8.9% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $156.62 million in FY2024 (-14.6%), $183.46 million in FY2023 (-55.2%), $409.59 million in FY2022 (+5.8%) and $387.06 million in FY2021 (+36.1%).
  • The Q2 2026 figure is the highest quarterly Cash & Current Investments since Q2 2024.
  • On a year-over-year basis, Cash & Current Investments has increased for three consecutive quarters, with an average decline of 3.4% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 93.6% in Q3 2021, against a decline of 57.5% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $189.24 million (Q1 2026), $178.08 million (Q4 2025) and $143.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Arcutis Biotherapeutics 3.16 Bn 2.44 Bn 118.92 Mn 204.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 204.43 Mn
Mar 31, 2026 189.24 Mn
Dec 31, 2025 178.08 Mn
Sep 30, 2025 143.95 Mn
Jun 30, 2025 118.08 Mn
Mar 31, 2025 144.98 Mn
Dec 31, 2024 156.62 Mn
Sep 30, 2024 195.71 Mn
Jun 30, 2024 278.17 Mn
Mar 31, 2024 213.77 Mn
Dec 31, 2023 183.46 Mn
Sep 30, 2023 227.11 Mn
Jun 30, 2023 268.67 Mn
Mar 31, 2023 332.41 Mn
Dec 31, 2022 409.59 Mn
Sep 30, 2022 476.96 Mn
Jun 30, 2022 282.17 Mn
Mar 31, 2022 343.60 Mn
Dec 31, 2021 387.06 Mn
Sep 30, 2021 367.27 Mn
API Access

Arcutis Biotherapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ARQT&period=max&api_key=YOUR_API_KEY